January 2026 Vol 19, No 1
As a pharmacist by trade, I have been an inventor and an entrepreneur my whole life. Long gone are the days of independent corner drug stores, but working in a drug store as a teenage girl inspired and shaped me in so many ways. Read More ›
On May 20, 2025, the FDA had a meeting of its Oncologic Drug Advisory Committee (ODAC). Read More ›
KEY WORDS: clinical trials, FDA, ODAC, oncology, regulatory
As an investor, it can be difficult to navigate the ups and downs of the market and understand what the movements mean for your portfolio— particularly when you’re seeing constant headlines on the topic. Read More ›
Clinical trial recruitment and retention remain challenges in the quest to bring innovative therapies to all patients in need. In oncology, therapies continue to evolve, yet researchers are frequently faced with low trial participation, particularly among minority groups. Read More ›
Encourage Your Patients to Participate!